Abstract
Administration of a single dose of tetrahydrobiopterin dihydrochloride, 10–20 mg/kg orally, to a patient with dihydrobiopterin deficiency led to disappearance of clinical symptoms for 4 days, normalization of urinary phenylalanine and serotonin and decrease of elevated neopterin for 2–3 days. A dose-dependent stimulation of serotonin production was observed. A similar effect was note with even lower doses of L-sepiapterin. The patient is now under monotherapy with tetrahydrobiopterin·2 HCl, 2.5 mg/kg daily. Other patients with this disease may not respond as well.
Results of screening for tetrahydrobiopterin deficiency in 228 cases with hyperphenylalaninemia, including 140 newborns, are reported.
There is evidence that biopterin biosynthesis in human kidney and liver proceeds via a dioxo compound and L-sepiapterin.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Smith I, Clayton BE, Wolff OH (1975) New variant of phenylketonuria with progressive neurological illness unresponsive to phenylalanine restriction. Lancet I:1108–1111
Bartholomé K (1974) A new molecular defect in phenylketonuria. Lancet II:1580
Kaufman S, Holtzman NA, Milstien S, Butler IJ, Krumholz A (1975) Phenylketonuria due to a deficiency of dihydropteridine reductase. New Eng J Med 293:785–790
Danks DM, Bartholomé K, Clayton BE, Curtius H-Ch, Gröbe H, Kaufman S, Leeming R, Pfleiderer W, Rembold H, Rey F (1978) Malignant hyperphenylalaninaemia—current status (June 1977). J Inher Metab Dis 1:49–53
Kaufman S, Berlow S, Summer GK, Milstien S, Schulman JD, Orloff S, Spielberg S, Pueschel S (1978) Hyperphenylalaninemia due to a deficiency of biopterin. A variant form of phenylketonuria. N Engl J Med 299:673–679
Niederwieser A, Curtius H-Ch, Bettoni O, Bieri J, Schircks B, Viscontini M, Schaub J (1979) Atypical phenylketonuria caused by 7,8-dihydrobiopterin synthetase deficiency. Lancet I:131–133
Curtius H-Ch, Niederwieser A, Viscontini M, Otten A, Schaub J, Scheibenreiter S, Schmidt H (1979) Atypical phenylketonuria due to tetrahydrobiopterin deficiency. Diagnosis and treatment with tetrahydrobiopterin, dihydrobiopterin and sepiapterin. Clin Chim Acta 93:251–262
Curtius H-Ch, Baerlocher K, Völlmin JA (1972) Pathogenesis of phenylketonuria: Inhibition of dopa and catecholamine synthesis in patients with phenylketonuria. Clin Chim Acta 42:235–239
Butler IJ, Koslow SH, Krumholz A, Holtzman NA, Kaufman S (1978) A disorder of biogenic amines in dihydropteridine reductase deficiency. Ann Neurol 3:224
Rey F, Harpey JP, Leeming RJ, Blair JA, Aicardi J, Rey J (1977) Les hyperphénylalaninémies avec activité normale de la phénylalanine-hydroxylase. Arch Franc Péd 34, Suppl 2:109–120
Tanaka T, Aihara K, Iwai K, Kohashi M, Tomita K, Narisawa K, Arai N, Yoshida H, Usui T (1981) Hyperphenylalaninemia due to impaired dihydrobiopterin biosynthesis. Eur J Ped 136:275–280
Tada K, Narisawa K, Arai N, Ogasawava Y, Ishizawa S (1980) A sibling case of hyperphenylalaninemia due to a deficiency of dihydropteridine reductase: Biochemical and pathological findings. Tohoku J Exp Med 132:123–131
Niederwieser A, Curtius H-Ch, Viscontini M, Schaub J, Schmidt H (1979) Phenylketonuria variants. Lancet II:550
Gál EM, Hanson G, Sherman A (1976) Biopterin I. Profile and quantitation in rat brain. Neurochem Res 1:511–523
Bartholomé K, Byrd DJ (1975) L-dopa and 5-hydroxytryptophan therapy in phenylketonuria with normal phenylalanine-hydroxylase activity. Lancet II:1042–1043
Kapatos G, Kaufman S (1981) Peripherally administered reduced pterins do enter the brain. Science 212:955–956
Berlow S, Madison, USA, personal communication
Schaub J, Däumling S, Curtius H-Ch, Niederwieser A, Bartholomé K, Viscontini M, Schircks B, Bieri JH (1978) Tetrahydrobiopterin therapy of atypical phenylketonuria due to defective dihydrobiopterin biosynthesis. Arch Dis Child 53:674–676
Niederwieser A, Curtius H-Ch, Gitzelmann R, Otten A, Baerlocher K, Blehová B, Berlow S, Gröbe H, Rey F, Schaub J, Scheibenreiter S, Schmidt H, Viscontini M (1980) Excretion of pterins in phenylketonuria and phenylketonuria variants. Helv Paed Acta 35:335–342
Danks DM, Cotton RGH, Schlesinger P (1975) Tetrahydrobiopterin treatment of variant form of phenylketonuria. Lancet II:1043
Endres W, Niederwieser A, Curtius H-Ch, Wang M, Ohrt B, Schaub J (1982) Helv Paed Acta, in press
Beck B and Güttler F, Copenhagen, personal communication
Gál EM, Nelson JM, Sherman AD (1978) Biopterin III: Purification and characterization of enzymes involved in the cerebral synthesis of 7,8-dihydrobiopterin. Neurochem Res 3:69–88
Tanaka K, Akino M, Hagi Y, Doi M, Shiota T (1981) The enzymatic synthesis of sepiapterin by chicken kidney preparations. J Biol Chem 256:2963–2972
Häusermann M, Ghisla S, Niederwieser A, Curtius H-Ch (1981) New aspects of bopterin biosynthesis in man. FEBS Letters 131: 275–278
Niederwieser A, Matasović A, Curtius H-Ch, Endres W, Schaub J (1980) 3′-Hydroxysepiapterin in patients with dihydrobiopterin deficiency. FEBS Letters 118:299–302
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Niederwieser, A., Curtius, H.C., Wang, M. et al. Atypical phenylketonuria with defective biopterin metabolism. Monotherapy with tetrahydrobiopterin or sepiapterin, screening und study of biosynthesis in man. Eur J Pediatr 138, 110–112 (1982). https://doi.org/10.1007/BF00441135
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00441135